Detalhe da pesquisa
1.
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Lancet Oncol
; 25(4): 463-473, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467131
2.
Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial.
Am J Hematol
; 96(9): 1112-1119, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050972
3.
The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States.
Mov Disord
; 34(2): 236-245, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30589953
4.
Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients.
BMC Neurol
; 19(1): 50, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940119
5.
Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma.
J Comp Eff Res
; 12(1): e220146, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417238
6.
A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada.
Pharmacoecon Open
; 7(2): 199-216, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334238
7.
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
Clin Lymphoma Myeloma Leuk
; 23(7): 515-526, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076367
8.
Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.
Value Health
; 15(1): 72-80, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22264974
9.
Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.
Ethn Health
; 17(3): 309-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22066691
10.
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial.
Leuk Lymphoma
; 63(2): 304-314, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34632935
11.
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States.
J Manag Care Spec Pharm
; 27(11): 1532-1544, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34714110
12.
Epidemiology, longitudinal treatment patterns and outcomes of chronic lymphocytic leukemia in Israel.
Leuk Lymphoma
; 62(5): 1136-1145, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33305641
13.
The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson's Disease Population.
Forum Health Econ Policy
; 23(2): 1-23, 2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33984886
14.
Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States.
Pharmacoeconomics
; 38(9): 941-951, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383129
15.
The effect of functional status impairment on nursing home admission risk among patients with advanced Parkinson's disease.
J Med Econ
; 23(3): 297-307, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31779508
16.
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.
Curr Med Res Opin
; 34(12): 2063-2073, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016901
17.
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.
J Med Econ
; 20(11): 1207-1215, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28895769
18.
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.
Mov Disord Clin Pract
; 4(6): 829-837, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242809
19.
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.
Blood Adv
; 6(15): 4553-4557, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35736670
20.
Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting.
Curr Med Res Opin
; 30(4): 529-36, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24156689